Enveric Biosciences (ENVB) Income from Non-Controlling Interests (2015 - 2021)

Enveric Biosciences has reported Income from Non-Controlling Interests for 7 years, with the latest figure at -$3.2 million in Q1 2021.

• Quarterly Income from Non-Controlling Interests fell 189.34% year-over-year to -$3.2 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$6.7 million (down 91.11% YoY) and the FY2020 annual result came in at -$7.0 million, down 190.99% from the prior year.
• Income from Non-Controlling Interests declined to -$3.2 million in Q1 2021 per ENVB's latest filing, from -$1.1 million in the prior quarter.
• Over five years, Income from Non-Controlling Interests peaked at $15388.0 in Q2 2017 and troughed at -$19.4 million in Q4 2018.
• A 5-year average of -$3.3 million and a median of -$564831.5 in 2017 frame the typical range for Income from Non-Controlling Interests.
• The sharpest annual moves came in 2018 and 2019: Income from Non-Controlling Interests slumped 104907.45% in 2018, then jumped 87.56% in 2019.
• Over 5 years, Income from Non-Controlling Interests stood at -$18504.0 in 2017, then plunged by 104907.45% to -$19.4 million in 2018, then surged by 87.56% to -$2.4 million in 2019, then surged by 54.03% to -$1.1 million in 2020, then slumped by 189.34% to -$3.2 million in 2021.
• According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$3.2 million, -$1.1 million, and -$2.4 million for Q1 2021, Q1 2020, and Q4 2019 respectively.